Bolazine capronate
| Clinical data | |
|---|---|
| Trade names | Roxilon Inject |
| Routes of administration | Intramuscular injection |
| Identifiers | |
| |
| Synonyms | Bolazine caproate; Bolazine hexanoate; Di(drostanolone capronate) azine; 2α-Methyl-5α-androstan-17β-ol-3-one 17β-hexanoate azine |
| ChemSpider | 8254591 |
| Chemical and physical data | |
| Formula | C52H84N2O4 |
| Molar mass | 801.247 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
Bolazine capronate (INN) (brand name Roxilon Inject), also known as bolazine caproate or bolazine hexanoate, as well as di(drostanolone capronate) azine or 2α-methyl-5α-androstan-17β-ol-3-one 17β-hexanoate azine, is a synthetic, injected anabolic-androgenic steroid (AAS) and derivative of dihydrotestosterone (DHT).[1][2] It is an androgen ester – specifically, the C17β hexanoate ester of bolazine.[1][2]
See also
References
- 1 2 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 653–. ISBN 978-1-4757-2085-3.
- 1 2 García-Manso, Juan Manuel; Valverde Esteve, Teresa (2016). "Consequences of the Use of Anabolic-Androgenic Steroids on Female Athletes' Fertility": 229–238. doi:10.1007/978-1-4939-3402-7_14.
This article is issued from Wikipedia - version of the 11/18/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.